Screening of Septo-optic Dysplasia During a Fetal Examinatio... | Clinical Trial | StuddyBuddy@endsection Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05717855

Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation

Conditions: 2D Ultrasound, Cavum Septum Pellucidum, Septooptic Dysplasia, Optic Chiasma, Willis Polygon

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 52
Sponsor: Gaziosmanpasa Research and Education Hospital

Location: Turkey

Summary

Evaluation of prenatal optic chiasm (OC) is important for the differential diagnosis of septo-optic dysplasia (SOD), which is a congenital optic disc anomaly, and the absence of the cavum septum pellucidum (CSP). Septo-optic dysplasia is associated with a wide range of neurological abnormalities, including hypoplasia of the visual pathways, CSP agenesis, and developmental delay.

Eligibility Criteria

Inclusion Criteria:aged greater than 18 years oldhaving singleton pregnancyExclusion Criteria:being under the age of 18having IVF pregnancyhaving multiple pregnancycomorbidity during pregnancysmoking historypresence of familial genetic disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05717855). StuddyBuddy aggregates publicly available trial information.